Skip to main content
. 2016 Aug 17;7(40):66255–66266. doi: 10.18632/oncotarget.11357

Figure 3. Proposed mechanism of CBFβ-SMMHC inhibitors.

Figure 3

Schematic representation of proposed CBFβ-SMMHC activities A. in the absence of inhibitors, or in the presence of B. Ro5-3335, C. AI-10-49, or D. 22d. Proteins are represented by the colored shapes labeled in (A). Ac: Acetylation group.